Blood Viscosity - Drug effects
Research News and Information

Monday, November 23, 2009

Supplementation with magnesium and vitamin E were more effective than magnesium alone to decrease plasma lipids and blood viscosity in diabetic rats.

29 Jun 2009 Although magnesium and vitamin E (VE) have differing effects on diabetes, both are beneficial. We hypothesized that preventive supplementation of magnesium combined with VE could improve the metabolism of lipids and blood viscosity more effectively ... Read more...

Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180.

6 Jun 2009 PURPOSE: We examined the activity of bortezomib, dexamethasone, and rituximab (BDR) in patients with symptomatic, untreated Waldenström macroglobulinemia (WM). PATIENTS AND METHODS: A cycle of therapy consisted of bortezomib 1.3 mg/m(2) ... Read more...

Bioavailability of salvianolic acid B and effect on blood viscosities after oral administration of salvianolic acids in beagle dogs.

25 May 2009 Salvianolic acid B (SalB) is an active component isolated from Chinese herbal medicine Salvia miltiorrhiza. The aim of this study was to investigate the extent of absolute oral bioavailability (F) of SalB in beagle dogs and the effect on blood ... Read more...

Latest indexed articles for 'Blood Viscosity - Drug effects'

These are the very latest articles for this heading:

• Supplementation with magnesium and vitamin E were more effective than magnesium alone to decrease plasma lipids and blood viscosity in diabetic rats. 29 Jun 2009
• Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180. 6 Jun 2009
• Bioavailability of salvianolic acid B and effect on blood viscosities after oral administration of salvianolic acids in beagle dogs. 25 May 2009
• Clinical observation of Danhong Injection (herbal TCM product from Radix Salviae miltiorrhizae and Flos Carthami tinctorii) in the treatment of traumatic intracranial hematoma. 6 May 2009
• Effect of the carthamins yellow from Carthamus tinctorius L. on hemorheological disorders of blood stasis in rats. May 2009
• Influence of albumin concentration in priming solution on blood viscosity under hypothermic conditions. 29 Apr 2009
• [Effects of Tianma Xingnao capsule on thrombosis and coagulation system] 27 Feb 2009
• Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases. 6 Jan 2009
• Age-related differences in pulmonary and cardiovascular responses to SiO2 nanoparticle inhalation: nanotoxicity has susceptible population. 29 Nov 2008
• Treatment with aspirin and dipyridamole is more effective than aspirin in reducing low shear blood viscosity. 29 Sep 2008
• Effect of desmopressin on erythrocyte aggregation. 30 Aug 2008
• [Effect of atorvastatin treatment on the hemorheologic and hemostatic parameters in chronic cerebrovascular patients] 13 Jun 2008
• [Effect of Mailuoning injectable powder on experimental vascular occlusion angeitides in rats] 30 May 2008
• [Cancer chemotherapy and anticoagulant prophylaxis] 30 May 2008
• Effect of immunoglobulin therapy on blood viscosity and potential concerns of thromboembolism, especially in patients with acute Kawasaki disease. 30 May 2008
• Temporal effect of Guanxin No. 2 on cardiac function, blood viscosity and angiogenesis in rats after long-term occlusion of the left anterior descending coronary artery. 26 May 2008
• Comparison of cardioprotective effects using salvianolic acid B and benazepril for the treatment of chronic myocardial infarction in rats. 22 May 2008
• Comparison of cardioprotective effects of salvianolic acid B and benazepril on large myocardial infarction in rats. 29 Apr 2008
• [Hemorheological activity of Gymnemy sylvestre extracts in streptozotocin-induced diabetes] 29 Apr 2008
• Effects of icariin combined with Panax notoginseng saponins on ischemia reperfusion-induced cognitive impairments related with oxidative stress and CA1 of hippocampal neurons in rat. 29 Apr 2008

See a longer list of these articles.

Technical information about 'Blood Viscosity'

Definition: The internal resistance of the BLOOD to shear forces. The in vitro measure of whole blood viscosity is of limited clinical utility because it bears little relationship to the actual viscosity within the circulation, but an increase in the viscosity of circulating blood can contribute to morbidity in patients suffering from disorders such as SICKLE CELL ANEMIA and POLYCYTHEMIA.

Descriptor UI: D001809

Alternative terms: Blood Viscosity; Blood Viscosities; Viscosities, Blood; Viscosity, Blood;

Related Mesh Headings: Hemorheology;

Allowable Qualifiers: drug effects; genetics; immunology; physiology; radiation effects; ethics;

Tree Number: G09.188.370.124; G09.330.380.630.110;

Technical Notes: coord IM with disease /blood (IM), not /physiopathol